ASCN Ascom Holding AG

Ascom Myco 3 smartphone gets certification from MEDITECH for the Expanse Point of Care EHR Solution

Ascom Myco 3 smartphone gets certification from MEDITECH for the Expanse Point of Care EHR Solution

Ascom announced that EHR provider MEDITECH has certified the Ascom Myco 3 smartphone with its Expanse Point of Care solution. Nurses, therapists, aides, and other clinicians can now complete most tasks on their handheld Ascom Myco 3 device – including receive alerts, document vitals and interventions, review records, and verify and administer medications using the smartphone’s built-in barcode scanner. Patients can also benefit from more quality caregiving time with their clinicians.

MEDITECH joins an increasing roster of prominent EHR companies to certify the healthcare device on its platform to meet the communication needs of medical organizations today and tomorrow.

Pamela Crandall, Senior Marketing Solution Manager at MEDITECH, says: “The Ascom Myco 3 device gives our customers another powerful option for accessing our Expanse Point of Care and wireless phlebotomy solutions through Dryrain's Enterprise browser. Nurses appreciate the mobility of using smartphone devices and the additional facetime it gives them with patients.”

Phlebotomists can also use the Ascom Myco 3 to access MEDITECH’s phlebotomy handheld solution to access a real-time list of specimens awaiting collection and print labels at the patient’s bedside. In addition, phlebotomists can use the barcode scanner to verify patient identification prior to specimen draw.

Francis Schmeer, Chief Sales Officer of Ascom, underlines: “We are delighted to partner with MEDITECH, a leading vendor and founder of the EHR market. The Ascom Myco 3, sold globally and in trials in many leading hospitals, is showing great results across the care continuum. Our aim with this smartphone designed for healthcare professionals is to provide mobility with confidence and improve clinician workflows at the point of care.”

For more information on the Ascom Myco 3 smartphone visit the website .

EN
02/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ascom Holding AG

 PRESS RELEASE

Ascom preliminary results 2025

Ascom preliminary results 2025 Ad hoc announcement pursuant to Art. 53 LRBaar (Switzerland), 15 January 2026Based on preliminary unaudited figures, Ascom reports for fiscal year 2025 net revenue of CHF 292.1 million, which is an increase of around 3.8% at constant currencies, and an EBITDA margin of around 11.5% to 12.0%. Ascom generated net revenue of CHF 292.1 million for fiscal year 2025 (2024: CHF 286.7 million), which reflects an increase of around 3.8% at constant currencies. At actual currencies, the generated revenue represents an increase of 1.9% compared to the previous year, bas...

 PRESS RELEASE

Ascom vorläufige Ergebnisse 2025

Ascom vorläufige Ergebnisse 2025 Ad hoc-Mitteilung gemäss Art. 53 KRBaar (Schweiz), 15. Januar 2026Basierend auf vorläufigen, ungeprüften Zahlen erzielte Ascom im Geschäftsjahr 2025 einen Umsatz von CHF 292,1 Mio., was einem Wachstum von rund 3,8% zu konstanten Wechselkursen entspricht, sowie eine EBITDA-Marge von rund 11,5% bis 12,0%. Ascom erreichte im Geschäftsjahr 2025 einen Nettoumsatz von CHF 292,1 Mio. (2024: CHF 286,7 Mio.). Im Vergleich zum Vorjahr entspricht dies einem Wachstum von rund 3,8% zu konstanten Wechselkursen und von 1,9% zu aktuellen Wechselkursen, basierend auf vorläu...

 PRESS RELEASE

Ascom ernennt David Hale zum neuen CEO

Ascom ernennt David Hale zum neuen CEO Ad hoc Mitteilung gemäss Art. 53 KRBaar, Schweiz, 9. Dezember 2025 Der Verwaltungsrat der Ascom Holding AG hat David Hale zum neuen CEO der Ascom Holding AG ernannt. David Hale verfügt über einen erstklassigen Leistungsausweis und mehr als zwanzig Jahre Führungserfahrung in der Technologie- und Industriebranche. Er tritt seine Position am 4. Februar 2026 an. Michael Reitermann gibt die Aufgaben des Interim-CEO zu diesem Zeitpunkt ab, bleibt aber weiterhin ordentliches Mitglied des Verwaltungsrats. David Hale verfügt über mehr als 25 Jahre internation...

 PRESS RELEASE

Ascom appoints David Hale as new CEO

Ascom appoints David Hale as new CEO Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, December 9, 2025 David Hale, an executive leader with a proven track record and over two decades of technology and industrial expertise, has been appointed by the Board of Directors of Ascom Holding AG as the new CEO of the Ascom Group. David Hale will join Ascom on February 4, 2026. Michael Reitermann will step down as interim CEO at that time and remain an ordinary member of the Board of Directors. David Hale has more than 25 years of international leadership experience in the medical devic...

Ascom Holding AG: 1 director

A director at Ascom Holding AG bought 20,000 shares at 3.435CHF and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch